A carregar...
Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study
INTRODUCTION: The glycopeptide teicoplanin is commonly utilized to facilitate outpatient parenteral antimicrobial therapy (OPAT). Licensed for once daily maintenance dosing, teicoplanin’s long half-life allows for less frequent dosing (e.g. thrice weekly) following successful loading. This service e...
Na minha lista:
| Publicado no: | JAC Antimicrob Resist |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8210249/ https://ncbi.nlm.nih.gov/pubmed/34223089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jacamr/dlab012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|